After misconduct at a key trial site raised questions of data integrity earlier this year, BioXcel Therapeutics’ Alzheimer’s agitation prospect faced a grim outlook. Now, with a third-party audit in ...
Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter 1 from the US Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback